Role of Semaphorins in Immunopathologies and Rheumatic Diseases.
Samuel García PérezPublished in: International journal of molecular sciences (2019)
Rheumatic diseases are disorders characterized by joint inflammation, in which other organs are also affected. There are more than two hundred rheumatic diseases, the most studied so far are rheumatoid arthritis, osteoarthritis, spondyloarthritis, systemic lupus erythematosus, and systemic sclerosis. The semaphorin family is a large group of proteins initially described as axon guidance molecules involved in nervous system development. Studies have demonstrated that semaphorins play a role in other processes such as the regulation of immunity, angiogenesis, bone remodeling, apoptosis, and cell migration and invasion. Moreover, semaphorins have been related to the pathogenesis of multiple sclerosis, asthma, Alzheimer, myocarditis, atherosclerosis, fibrotic diseases, osteopetrosis, and cancer. The aim of this review is to summarize current knowledge regarding the role of semaphorins in rheumatic diseases, and discuss their potential applications as therapeutic targets to treat these disorders.
Keyphrases
- systemic sclerosis
- interstitial lung disease
- rheumatoid arthritis
- disease activity
- systemic lupus erythematosus
- multiple sclerosis
- oxidative stress
- ankylosing spondylitis
- healthcare
- chronic obstructive pulmonary disease
- papillary thyroid
- single cell
- endothelial cells
- endoplasmic reticulum stress
- bone mineral density
- lung function
- idiopathic pulmonary fibrosis
- cell therapy
- cell death
- squamous cell carcinoma
- vascular endothelial growth factor
- cell cycle arrest
- cognitive decline
- squamous cell
- risk assessment
- white matter
- air pollution
- climate change
- signaling pathway
- human health
- knee osteoarthritis
- body composition
- bone marrow
- case control
- optic nerve